Explore more topics
News sentiment

Tenax Therapeutics, Inc. (TENX) news sentiment

How positive or negative Tenax Therapeutics, Inc.'s news headlines have been since Sep 23, 2019, week by week, with the last 90 sessions day by day and each recent headline's tone and source.

As of 2026-10-29

Average tone, last 30 sessions
-10From -100 (every headline negative) to +100 (every headline positive)
Headlines, last 30 sessions
20
Headlines, last 90 sessions
52
Change from the 90-session average
-6
Latest session
2026-10-29

Weekly headline tone since September 2019

Hover a week for its biggest stories; click to pin.

Tone8-week averageHeadlinesFiltered out (passing mentions)
Every week since Sep 23, 2019
TENX headline tone: Every week since Sep 23, 2019, 152 weeks from September 23, 2019 to October 19, 2026.-100-75-50-25+25+50+75+1000Headlines2020202120222023202420252026

Coverage of Tenax Therapeutics, Inc. over the last 30 trading sessions is negative (-10) across 20 headlines, 20 points below its one-year average of +10. The most widely carried story in the week of Oct 19, 2026 was "Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 Shares", carried by 1 outlet.

Each point is one week of headlines about Tenax Therapeutics, Inc.: the share of positive minus negative headlines, from -100 to +100, with the 8-week average drawn through it and the number of headlines beneath. Since coverage began, 301 headlines average +15.

Jump to a section

Tone mix

TENX headlines by tone, last 52 weeks
positive
15%
neutral
80%
negative
5%

Week by week 51 weeks

Sep 2, 2024: 0 positive, 2 neutral, 0 negativeSep 9, 2024: 0 positive, 1 neutral, 0 negativeSep 16, 2024: 0 positive, 1 neutral, 1 negativeSep 23, 2024: 0 positive, 1 neutral, 0 negativeSep 30, 2024: 0 positive, 1 neutral, 0 negativeOct 14, 2024: 0 positive, 1 neutral, 0 negativeOct 28, 2024: 0 positive, 1 neutral, 0 negativeNov 11, 2024: 0 positive, 2 neutral, 0 negativeDec 30, 2024: 0 positive, 2 neutral, 0 negativeJan 20, 2025: 0 positive, 1 neutral, 0 negativeFeb 3, 2025: 0 positive, 1 neutral, 0 negativeFeb 10, 2025: 0 positive, 1 neutral, 0 negativeMar 3, 2025: 3 positive, 4 neutral, 0 negativeMar 10, 2025: 0 positive, 2 neutral, 0 negativeMar 24, 2025: 2 positive, 4 neutral, 0 negativeMar 31, 2025: 0 positive, 3 neutral, 0 negativeApr 7, 2025: 0 positive, 2 neutral, 0 negativeApr 14, 2025: 0 positive, 1 neutral, 0 negativeMay 19, 2025: 0 positive, 1 neutral, 0 negativeAug 11, 2025: 0 positive, 1 neutral, 0 negativeAug 25, 2025: 0 positive, 1 neutral, 0 negativeSep 15, 2025: 1 positive, 0 neutral, 0 negativeNov 3, 2025: 0 positive, 1 neutral, 0 negativeNov 17, 2025: 1 positive, 1 neutral, 0 negativeNov 24, 2025: 0 positive, 1 neutral, 0 negativeDec 1, 2025: 0 positive, 1 neutral, 0 negativeDec 8, 2025: 0 positive, 2 neutral, 0 negativeDec 15, 2025: 0 positive, 1 neutral, 0 negativeJan 5, 2026: 1 positive, 0 neutral, 0 negativeJan 12, 2026: 1 positive, 0 neutral, 0 negativeFeb 2, 2026: 0 positive, 1 neutral, 0 negativeFeb 16, 2026: 0 positive, 1 neutral, 0 negativeMar 2, 2026: 0 positive, 1 neutral, 0 negativeMar 9, 2026: 1 positive, 2 neutral, 0 negativeMar 23, 2026: 0 positive, 1 neutral, 0 negativeApr 20, 2026: 0 positive, 1 neutral, 0 negativeMay 11, 2026: 0 positive, 2 neutral, 0 negativeJun 15, 2026: 1 positive, 0 neutral, 0 negativeJun 22, 2026: 0 positive, 1 neutral, 0 negativeJun 29, 2026: 0 positive, 2 neutral, 0 negativeJul 6, 2026: 0 positive, 3 neutral, 0 negativeJul 13, 2026: 1 positive, 2 neutral, 0 negativeJul 27, 2026: 0 positive, 2 neutral, 0 negativeAug 3, 2026: 1 positive, 2 neutral, 0 negativeAug 10, 2026: 1 positive, 3 neutral, 4 negativeAug 17, 2026: 0 positive, 1 neutral, 0 negativeAug 24, 2026: 1 positive, 2 neutral, 0 negativeAug 31, 2026: 0 positive, 6 neutral, 0 negativeSep 14, 2026: 0 positive, 1 neutral, 0 negativeSep 28, 2026: 0 positive, 1 neutral, 0 negativeOct 19, 2026: 0 positive, 2 neutral, 0 negative
Sep 2, 2024Oct 19, 2026

Share of Tenax Therapeutics, Inc.'s 98 headlines over the last 52 weeks by the model's call, and the same mix week by week.

Biggest swings in the last year

The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.

Daily headline tone, last 90 sessions

Hover a session for its totals; click to pin.

Session tone8-session averageHeadlines
Last 23 sessions with a headline
TENX average headline tone by session: Last 23 sessions with a headline, 23 sessions from July 2, 2026 to October 29, 2026.-100-75-50-25+25+50+75+1000HeadlinesJul 2026AugSepOct

Each point is the average score of the headlines about Tenax Therapeutics, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.

Tone by period

Show the table · 3 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Last 7 sessions19-10
Last 30 sessions20-10
Last 90 sessions52-4

Every headline in the period counts equally.

Headlines on Thursday, October 29, 2026

4 headlines, average tone 0: 0 positive, 4 neutral and 0 negative. Showing all 4.

Show the table · 4 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Lost Money on Tenax Therapeutics, Inc. (TENX)? Contact Levi & Korsinsky ...www.pr-inside.com1Neutral
TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuitwww.prnewswire.com1Neutral
TENX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces ...www.pr-inside.com1Neutral
Kaplan Fox Encourages Investors of Tenax Therapeutics, Inc. (NASDAQ:TENX) ...www.pr-inside.com1Neutral

Headlines on Wednesday, October 28, 2026

12 headlines, average tone -17: 0 positive, 10 neutral and 2 negative. The 8 most widely carried stories are listed; the table holds all 12.

Show the table · 12 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Investor Alert: Deadline Approaching to Join Tenax Therapeutics, Inc. ...www.pr-inside.com2Neutral
Shareholders of Tenax Therapeutics, Inc. (TENX): Protect Your Rights ...www.pr-inside.com2Neutral
Levi & Korsinsky Notifies Tenax Therapeutics, Inc. (TENX) Shareholders ...www.pr-inside.com2Neutral
Join Class Action to Recover Losses From Tenax Therapeutics, Inc. (TENX) ...www.pr-inside.com2Neutral
Securities Fraud Class Action Filed Against Tenax Therapeutics, Inc. ...www.pr-inside.com1Negative
Recover Investment Losses: Class Action Initiated Against Tenax Therapeutics, ...www.pr-inside.com1Negative
Tenax Therapeutics, Inc. (TENX) Class Action Lawsuit: Levi & Korsinsky ...www.pr-inside.com1Neutral
Investors in Tenax Therapeutics, Inc. (TENX): Protect Your Rights - ...www.pr-inside.com1Neutral
Levi & Korsinsky Urges Tenax Therapeutics, Inc. (TENX) Shareholders ...www.pr-inside.com1Neutral
TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc.www.prnewswire.com1Neutral
Lost Money on Tenax Therapeutics, Inc. (TENX)? Contact Levi & Korsinsky ...www.pr-inside.com1Neutral
TENX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics ...www.pr-inside.com1Neutral

Headlines on Tuesday, October 27, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

  • www.gazettextra.com · 1 outletInvestor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action LawsuitNeutral
Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuitwww.gazettextra.com1Neutral

Headlines on Thursday, October 22, 2026

2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.

Show the table · 2 rows, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Tenax Therapeutics (NASDAQ:TENX) Major Shareholder Adar1 Capital Management, Llc Acquires 336,528 Shares of Company Stockwww.themarketsdaily.com1Neutral
Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 Shareswww.dailypolitical.com1Neutral

Headlines on Friday, October 2, 2026

1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.

Show the table · 1 row, 4 columns

Scroll sideways to compare all columns. Select a heading to sort.

Tenax Therapeutics, Inc. (NASDAQ:TENX) Stock Has Average Target Price of $14.00 According to Brokerageswww.dailypolitical.com1Neutral

How the score works

A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.

  1. Which headlines count

    Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Tenax Therapeutics, Inc., not a passing mention.

  2. How each headline is scored

    The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).

  3. When a headline counts

    Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.

  4. Repeated stories

    When several outlets carry the same headline, it counts once per session.